Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
AstraZeneca
Boehringer Ingelheim
Mallinckrodt
Merck
McKinsey

Last Updated: November 14, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Cryoprecipitate

See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug Cryoprecipitate?

Cryoprecipitate is an investigational drug.

There have been 22 clinical trials for Cryoprecipitate. The most recent clinical trial was a Phase 2 trial, which was initiated on July 1st 2008.

The most common disease conditions in clinical trials are Blood Coagulation Disorders, Hemostatic Disorders, and Hemorrhage. The leading clinical trial sponsors are CSL Behring, Australian Red Cross, and Gold Coast Hospital and Health Service.

Recent Clinical Trials for Cryoprecipitate
TitleSponsorPhase
A Clinical Study of Anfibatide in Acquired Thrombotic Thrombocytopenic Purpura (TTP)Lee's Pharmaceutical LimitedPhase 2
In Vivo Effects of Fibrinogen Concentrate (FC) Versus Cryoprecipitate on the Neonatal Fibrin Network Structure After Cardiopulmonary Bypass (CPB)Emory UniversityPhase 3
Fibrinogen Concentrate In Children Cardiac Surgery 2Filomena R B G GalasPhase 4

See all Cryoprecipitate clinical trials

Clinical Trial Summary for Cryoprecipitate

Top disease conditions for Cryoprecipitate
Top clinical trial sponsors for Cryoprecipitate

See all Cryoprecipitate clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Mallinckrodt
Moodys
Baxter
Merck
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.